Stockwinners Market Radar for November 23, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

13:31 EDT Milestone Scientific receives noncompliance letter from NYSE American LLC - Milestone Scientific Inc. announced that on November 20, 2018, it received a letter from NYSE American LLC stating that it is not in compliance with the continued listing standards as set forth in Section(s) 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide. In order to maintain its listing, the Company must submit a plan of compliance by December 20, 2018 addressing how it intends to regain compliance with Section(s) 1003(a)(i), (ii) and (iii) of the Company Guide by May 20, 2020. If the plan is accepted, the Company may be able to continue its listing but will be subject to periodic reviews by the Exchange. If the plan is not accepted or if it is accepted but the company is not in compliance with the continued listing standards by May 20, 2020, or if the company does not make progress consistent with the plan, the Exchange will initiate delisting procedures as appropriate. The company's management is pursuing options to address the deficiency and intends to submit a compliance plan on or before the deadline set by the Exchange.

12:16 EDT AstraZeneca granted orphan status for eosinophilic granulomatosis treatment - AstraZeneca's benralizumab was granted FDA orphan designation as a treatment of eosinophilic granulomatosis with polyangiitis, according to a post to the agency's website. Reference Link

12:00 EDT GeoPark falls -13.8% - GeoPark is down -13.8%, or -$2.35 to $14.73.

12:00 EDT Bristow Group falls -25.8% - Bristow Group is down -25.8%, or -$1.59 to $4.58.

12:00 EDT Scor ADR rises 12.0% - Scor ADR is up 12.0%, or $2.78 to $25.96.

10:19 EDT A10 Networks jumps after report of exploring potential sale - Shares of A10 Networks have jumped by over 5% after Reuters said the company is exploring options that include a potential sale. A10's deliberations are at an early stage, Reuters noted.

10:07 EDT Weichai Power reports 19.9% stake in Ballard Power - Ballard and Weichai Power have entered into a subscription agreement to provide for the issuance and sale by Ballard to Weichai Power or its designated Affiliate of common shares in the capital of Ballard representing approximately 19.9% of the outstanding Common Shares; Weichai Power has designated Weichai to acquire and hold the Subscription Shares of Ballard prior to the Closing; Ballard and Weichai have agreed to enter into this Agreement to provide for certain rights and restrictions in connection with Weichai's on-going rights to sell or transfer the Common Shares it acquires under the Placement and to acquire further Common Shares.

10:00 EDT Universal Compression falls -12.0% - Universal Compression is down -12.0%, or -$2.35 to $17.20.

10:00 EDT Rockwell Collins rises 9.1% - Rockwell Collins is up 9.1%, or $11.78 to $141.46.

10:00 EDT Britannia Bulk rises 17.7% - Britannia Bulk is up 17.7%, or $2.06 to $13.71.

09:50 EDT FRONTEO Inc (ADS) trading resumes

09:47 EDT California Resources falls -9.1% - California Resources is down -9.1%, or -$2.28 to $22.82.

09:47 EDT Navios Acquisition rises 10.0% - Navios Acquisition is up 10.0%, or 66c to $7.26.

09:47 EDT Britannia Bulk rises 16.5% - Britannia Bulk is up 16.5%, or $1.92 to $13.57.

09:13 EDT Macy's CEO says 'most great retailers' are 'very controlled' now on inventories - Macy's CEO Jeff Gennette is being interviewed on CNBC.

09:03 EDT Fly Intel: Pre-market Movers - HIGHER: Rockwell Collins (COL) up 8% after the company received conditional approval from China to be acquired by United Technologies (UTX)... Overstock.com (OSTK), up 5% after the Wall Street Journal reports that the company plans to complete the sale of its retail business by February. LOWER: United Technologies, down 1% after confirming Chinese approval for the acquisition of Rockwell Collins... Facebook (FB), down 1% after The Wall Street Journal reports Patrick Gaspard, president of George Soros's Open Society Foundations, called for congressional oversight of Facebook by U.S. lawmakers after the company confirmed it hired Definers Public Affairs to research Soros... Ability (ABIL), down 38% after raising 10M in a common stock and warrant offering... Visa (V), down 1% after Reuters reports Visa and Mastercard (MA) have offered to reduce the fees merchants pay on card payments by tourists in the European Union in an attempt to stave off possible fines from an antitrust investigation... Credit Suisse (CS), down 1.5% after RBC Capital analyst Anke Reingen downgraded the stock to Sector Perform. A re-rating higher of shares in the near-term will be difficult amid pressure on revenue and limited scope to cut more costs, Reingen tells investors in a research note.

08:27 EDT Orchids Paper jumps almost 240% after securing new customer, amends credit pact - Shares of Orchids Paper are up 235.31% in pre-market trading on Friday after announcing on Wednesday evening, ahead of the Thanksgiving break, that company has reached an agreement with its creditors, amending its credit agreement. The company also announced that it has won a significant bid with a new customer, to supply 100% recycled ultra-premium quality tissue. Jeff Schoen, President, and CEO stated, "Our lenders continue to support and maintain access to the liquidity needed to operate our business. Shares of Orchids Paper are up $1.60 per share or 235.1% to $2.17 per share in pre-market trading.

08:04 EDT SCG Capital reports 9.99% passive stake in BioRestorative Therapies

07:10 EDT Yulong Eco-Materials receives determination letter from Nasdaq - Yulong Eco-Materials announced that it has received an additional determination letter from Nasdaq dated November 19. The company does not comply with Nasdaq's filing requirements for continued inclusion set forth in listing rule 5250 because it has not filed its Form 20-F for the period ended June 30. Accordingly, this matter serves as an additional basis for delisting the company's securities from Nasdaq. A company that receives a delist determination for delinquency, can request an appeal to a Hearings Panel, pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 series. A request for a hearing regarding a delinquent filing will stay the suspension of the company's securities only for a period of 15 days from the date of the request. In that regard, since the company is already before a hearings panel for its failure to comply with Listing Rule 5110, the company will have seven days, or until November 26, to request a stay of the suspension, pending a Hearings Panel decision. The request should include an explanation of why an extended stay is appropriate. A panel will review the request for an extended stay and notify the company of its conclusion as soon as is practicable but in any event no later than 15 calendar days following the deadline to request a further stay. The company intends to promptly comply with this Nasdaq directive.

07:03 EDT Grifols in talks for $5B stake in China's Shanghai RAAS Blood Products - Grifols S.A. disclosed on Wednesday that it has started conversations with Shanghai RAAS Blood Products in order to make an investment in the company, which is listed on the Shenzhen Stock Exchange. Grifols would invest in Shanghai RAAS by means of the contribution of its fully owned U.S. subsidiary, Grifols Diagnostic Solutions and its subsidiaries, receiving in exchange Shanghai RAAS newly issued shares. According to the negotiation, the valuation of 100% shares of Grifols Diagnostic Solutions is approximately $5B. Shanghai RAAS is a "market leader in the field of plasma derived medicinal products in China," according to Grifols. Shanghai RAAS has a total of 41 plasma collection centres in China with a fractionation capacity of more than 2M litre. The annual plasma collection in 2017 was approximately of 1.1M litres. Both parties have achieved an initial intent to cooperate. The structure of the transaction and the relevant due diligence are still being discussed.

06:47 EDT Elon Musk claims to be 'singing off for a while' from Twitter - After wishing followers a Happy Thanksgiving Wednesday night on Twitter, Tesla CEO Elon Musk tweeted that he's "signing off for a while." Musk did not provide further details on Twitter. Shares of Tesla are down $2.82 to $335.37 in premarket trading.

06:23 EDT BP begins Clair Ridge production - BP (BP), on behalf of co-venturers Shell (RDS.A), Chevron (CVX) and ConocoPhillips (COP) announced first oil production from the giant Clair Ridge project in the West of Shetland region offshore UK. Clair Ridge is the second phase of development of the Clair field, 75 kilometres West of Shetland. The field, which was discovered in 1977, has an estimated seven billion barrels of hydrocarbons. Two new, bridge-linked platforms and oil and gas export pipelines have been constructed as part of the Clair Ridge project. The new facilities, which required capital investment in excess of GBP 4.5 billion, are designed for 40 years of production. The project has been designed to recover an estimated 640 million barrels of oil with production expected to ramp up to a peak at plateau level of 120,000 barrels of oil per day. Clair Ridge is the first offshore deployment of BP's enhanced oil recovery technology, LoSal, which has the potential to increase oil recovery from reservoirs by using reduced salinity water in water injection. This is expected to result in up to 40 million additional barrels being cost-effectively recovered over the lifetime of the development. In addition to the platforms, the Clair Ridge project also included new pipeline infrastructure with the installation of a 5.5-kilometre, 22-inch oil export pipeline tying into the Clair Phase 1 export pipeline. Oil from Clair is exported to the Sullom Voe Terminal on Shetland. A new 14.6-kilometre, six-inch gas export pipeline tying Clair Ridge into the West of Shetland Pipeline Systems was also installed as part of the project. The WOSPS transports gas from West of Shetland to the Sullom Voe Terminal. Clair Ridge also features an advanced drill rig which will deliver a drilling programme over several years. There are 36 well slots, two of which are being used for the tieback of pre-drilled wells. The drilling programme, which is likely to last more than 10 years, includes drilling and completing development wells from the remaining 34 well slots. The start of production of Clair Ridge follows the start-up earlier in 2018 of five other Upstream major projects: Atoll Phase One, offshore Egypt, Shah Deniz 2 gas development in Azerbaijan, TAAS expansion project in Russia, Western Flank B offshore Western Australia and Thunderhorse Northwest Expansion in the Gulf of Mexico. This string of developments will follow from 2017's seven major project completions and is key to delivering the 900,000 barrels of oil equivalent new production that BP expects from new upstream major projects by 2021.

06:13 EDT Gridsum announces Nasdaq stay request granted - Gridsum announced that the Nasdaq Hearings Panel has granted the company's request for a further stay of any suspension action by Nasdaq pending the issuance of the panel's determination regarding the company's listing status following the hearing. On November 6, the company requested a hearing before the panel to appeal the delisting determination from the staff of the Listing Qualifications Department of Nasdaq, which automatically stayed the delisting of the company's securities for 15 calendar days. At the time of the request, the company also requested an extension of the stay beyond the 15-day period. The panel notified the company that it had granted the request to extend the stay, allowing for the continued trading of the company's American depositary shares on Nasdaq until a final determination regarding the Company's listing status is issued after its hearing. The Company's hearing before the panel is scheduled for December 13. The company continues to make significant progress in working with its independent auditors to finalize its audited financial statements as of and for the years ended December 31, 2015, 2016 and 2017, and to file its annual report on form 20-F for the year ended December 31, 2017.

05:26 EDT Novartis announces EC approval of Luxturna - Novartis (NVS) announced today that the European Commission, or EC, approved Luxturna, a one-time gene therapy for the treatment of patients with vision loss due to a genetic mutation in both copies of the RPE65 gene and who have enough viable retinal cells. The authorization is valid in all 28 member states of the EU, as well as Iceland, Liechtenstein and Norway. Luxturna was developed and is commercialized in the U.S. by Spark Therapeutics (ONCE).

05:19 EDT Delta Technology receives Nasdaq letter of non-compliance - Delta Technology Holdings announced that on November 19, 2018, the company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market notifying the company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1). The Nasdaq Listing Rules requires listed companies to maintain stockholders' equity of at least $2.5M. In the company's Form 20-F for the period ended June 30, the company reported a negative stockholders' equity of approximately $22M, which is below the minimum stockholders' equity required for continued listing pursuant to the Nasdaq Listing Rules. The notification received has no immediate effect on the listing of the company's common stock on Nasdaq. Nasdaq has provided the company with 45 calendar days, or until January 3, 2018, to submit a plan to regain compliance with the minimum stockholders' equity standard. If the company's plan to regain compliance is accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of the notification letter, or until May 18, 2019, to evidence compliance. The company, by filing this press release, discloses its receipt of the notification from Nasdaq in accordance with Nasdaq Listing Rule 5810(b).

05:14 EDT Cellcom Israel enters into MOU with Israel Infrastructure Fund - Cellcom Israel announced that following the company's previous reports regarding the company entering into an MOU for an investment in Israel Broadband Company, or IBC, the company entered into a memorandum of understanding with the Israel Infrastructure Fund, or IIF, for IIF's co-investment in IBC together with the company, which shall be carried out in equal parts between the company and IIF through a joint investment vehicle. The IIF MOU includes, in addition to standard and customary conditions, principles of cooperation between the parties towards the execution of the definitive agreements for the investment in IBC, which shall be carried out in accordance with the IBC MOU, and other transaction documents and after the consummation of such investment in IBC, if and when occurs, including, among others, joint decision making processes and equal participation in costs and financing of the investment, as well as certain adjustments in case an additional strategic investor joins the company and IIF in investing in IBC.